Join us at AMP this week to learn about the new generation of IVL! #BoltIVL
Looking forward to AMP this week! Let’s connect! Learn more about Bolt IVL and join Prof Marianne Brodmann as she presents the updated data from 75 patients in the RESTORE ATK clinical study on Friday, August 16th at 10:51am #BoltIVL
The Hippo pathway and TEAD are an important focus of EHE research. To help us understand these complex topics, David Casimir, PhD, JD gave an engaging patient-level presentation in June 2023 that remains a valuable resource. He addressed the questions: ✔️ What are the Hippo pathway and TEAD? ✔️ How do they relate to EHE? ✔️ How are they being used to develop EHE treatments? ✔️ How do these treatments move from the laboratory, through clinical trials, to patient care? Check out the link below to view the recording: https://lnkd.in/gAuSTqJm #EHE #fightEHE #EHEawareness #justlive #EHEcommunityconnections
View our infographic that summarizes key results from our Phase 3 UC clinical program, highlighting corticosteroid-free efficacy and a corticosteroid-sparing effect in treating UC. https://www.pfi.sr/ciH
Why are FOP toes bent and short? Well...they're missing a joint! Sometimes this happens in the thumbs too. It's another example of the many impacts FOP has on a person's body and it's why we are working so hard to learn all that we can through research and clinical studies and trials. #FOPAwareness
🌟 Are you curious about participating in a #SpinalCordInjury clinical trial but uncertain about what's involved? Download the #SCITrialsFinder guide to taking part in a clinical study at: https://lnkd.in/eKY4MdAE 🔗
To celebrate #ClusterHeadacheDay we are sharing recent papers from the Journal of Headache and Pain, first Dr Medrea shares insight on her article: Commentary on 2022 guidelines on clinical trial design in cluster headache and further suggestions https://lnkd.in/e2NQKuMP
❄️In our January issue Have you ever heard about the win-ratio? It is a method of analysis of clinical trials with composite outcome measures based on two (censored) time-to-event variables. David Oakes (University of Rochester Medical Center) discusses the intransitivity of win-ratio preferences and presents some general properties of the method. https://lnkd.in/dabQXgvG
Listen to a discussion of "Arteriovenous Access for Hemodialysis" in this JAMA Clinical Review. https://ja.ma/3IDxwrL
When you combine a larger diameter nasal prong with a smaller diameter nasal prong, you get asymmetrical nasal high flow. This webinar aims to coalesce emerging evidence, engineering and physiology as it currently applies to nasal high flow therapy. Click below for more details.
Want to join us for an in-depth look at the emerging evidence for asymmetrical nasal high flow? Join Fisher & Paykel Healthcare’s Director of Clinical Affairs, Chris Hutchinson, on Friday, June 28, for this information-filled, two-part webinar that will also explore enhancements to key mechanisms of action for nasal high flow. Sign up for part one of this free webinar series set for Friday, June 28. Morning: 9am PDT / 11am CDT / 12pm EDT https://lnkd.in/g3TrDawr Afternoon (recorded event): 1pm PDT / 3pm CDT / 4pm EDT https://lnkd.in/g8hufnxn
Discover how ESWT helped participants in all three clinical study groups; post-treatment VAS and FFI were statistically significantly lower than initial pretreatment values. https://hubs.la/Q01FYkRw0
